companydata.dkbiomee ApS: Financial statements 2017
CVR: 29829586
biomee ApS (CVR 29829586) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -7,813,359 and a net result of DKK -4,230,706 compared with DKK -38,706,747 the year before. Equity amounted to DKK -50,071,760.
- Gross Profit
- -7,813,359 kr.
- Profit/Loss
- -4,230,706 kr.
- Equity
- -50,071,760 kr.
- Total Assets
- 4,625,119 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -7.8 mio. | -4.2 mio. | -50.1 mio. | - |
| 2016 | - | -33 mio. | -38.7 mio. | -45.8 mio. | - |
| 2015 | - | -32.2 mio. | -33 mio. | -7.1 mio. | - |
| 2014 | - | -18.3 mio. | -17.2 mio. | -78.7 mio. | - |
| 2013 | - | -15.5 mio. | -18.6 mio. | -61.4 mio. | - |
Find more companies like biomee ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
As of December 29, 2017, MC2 Therapeutics A/S is registered as an owner of biomee ApS with an ownership share of 100%.
Biomee ApS has published its annual report for 2016. Gross profit came to DKK -33,025,329, and the net result was DKK -38,706,747.
About biomee ApS
biomee ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DRUG DELIVERY SOLUTIONS ApS and TOXICELL ApS. The management consists of Trine Ahlgreen. The company is owned by MC2 Therapeutics A/S. In 2025, the company reported a gross profit of DKK 4,813,840 and a net result of DKK 6,548,744 compared with DKK 5,547,134 the year before. Equity amounted to DKK 23,772,837.